mCRC PICKED A FIGHT,

NOW, I’M PICKING STIVARGA

Learn more about how
STIVARGA may help.

Learn more about how STIVARGA may help.

STIVARGA* is a chemo-free oral option used in previously treated mCRC.

*STIVARGA is a multikinase inhibitor.
mCRC=Metastatic Colorectal Cancer.

STIVARGA® (regorafenib)

STIVARGA is a once-daily, oral prescription anticancer medicine approved by the FDA for people with mCRC, GIST, and HCC

Pill bottle
Disease icon 1

CRC STIVARGA for colon or rectal cancer (CRC)

CRC that has spread to other parts of the body and for which they have received previous treatment with certain chemotherapy medicines.

STIVARGA in mCRC
Disease icon 2

GIST STIVARGA for gastrointestinal stromal tumor (GIST)

A rare stomach, bowel, or esophagus cancer that cannot be treated with surgery or that has spread to other parts of the body and for which they have received previous treatment with certain medicines.

GIST
Disease icon 3

HCC STIVARGA for hepatocellular carcinoma (HCC)

STIVARGA is indicated for patients with a type of liver cancer called hepatocellular carcinoma in people who have been previously treated with sorafenib.

HCC